The laboratory at Rikshospitalet, with pharmacologist Stein Bergan, specialist bioengineer Antonio Manuel Quiogue, and the head of the statin pharmacology project Nils Tore Vethe.

Using clinical data and blood samples biobanked in the NORCOR cohort study, we will describe the prevalence of high, reduced, and low/no statin adherence using our newly developed methods in over 500 coronary patients. The study also provides new insights into the reliability of self-reported medication adherence.